- Home
- AIRT vs AIDX Comparison
AIRT vs AIDX Comparison
Compare AIRT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | AIDX |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | 646 | N/A |
| Industry | Air Freight/Delivery Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5M | 58.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRT | AIDX |
|---|---|---|
| Price | $21.80 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.9K | ★ 199.8K |
| Earning Date | 02-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.56 | $1.51 |
| 52 Week High | $26.70 | $14.09 |
Technical Indicators
Market Signals| Indicator | AIRT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 12.54 |
| Support Level | $20.30 | $1.60 |
| Resistance Level | $21.09 | $3.08 |
| Average True Range (ATR) | 0.47 | 0.28 |
| MACD | -0.09 | 0.24 |
| Stochastic Oscillator | 14.61 | 29.32 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.